Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adrenergic signaling in cardiomyocytes 💬
 1件: ADRB1 💬 D00235 💬 Atenolol 1件: 167 💬
2 Adrenergic signaling in cardiomyocytes 💬
 1件: ADRB1 💬 D05127 💬 Nebivolol 4件: 17, 85, 113, 167 💬
3 Adrenergic signaling in cardiomyocytes 💬
 2件: ADRB1, ADRB2 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
4 Adrenergic signaling in cardiomyocytes 💬
 2件: ADRB1, ADRB2 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
5 Adrenergic signaling in cardiomyocytes 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
6 Adrenergic signaling in cardiomyocytes 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
7 Adrenergic signaling in cardiomyocytes 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
8 Adrenergic signaling in cardiomyocytes 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
9 Adrenergic signaling in cardiomyocytes 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
10 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
11 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
12 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
13 Aldosterone synthesis and secretion 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
14 Aldosterone synthesis and secretion 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
15 Aldosterone synthesis and secretion 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
16 Aldosterone synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
17 Aldosterone synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
18 Alzheimer disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
19 Alzheimer disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
20 Amphetamine addiction 💬
 2件: CACNA1C, CACNA1D 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
21 Amphetamine addiction 💬
 2件: CACNA1C, CACNA1D 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
22 Apelin signaling pathway 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
23 Apelin signaling pathway 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
24 Apelin signaling pathway 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
25 Arrhythmogenic right ventricular cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
26 Arrhythmogenic right ventricular cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
27 Calcium signaling pathway 💬
 1件: ADRB1 💬 D00235 💬 Atenolol 1件: 167 💬
28 Calcium signaling pathway 💬
 1件: ADRB1 💬 D05127 💬 Nebivolol 4件: 17, 85, 113, 167 💬
29 Calcium signaling pathway 💬
 3件: ADRB1, ADRB2, ADRB3 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
30 Calcium signaling pathway 💬
 3件: ADRB1, ADRB2, ADRB3 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
31 Calcium signaling pathway 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
32 Calcium signaling pathway 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
33 Calcium signaling pathway 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
34 Calcium signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
35 Calcium signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
36 cAMP signaling pathway 💬
 1件: ADRB1 💬 D00235 💬 Atenolol 1件: 167 💬
37 cAMP signaling pathway 💬
 1件: ADRB1 💬 D05127 💬 Nebivolol 4件: 17, 85, 113, 167 💬
38 cAMP signaling pathway 💬
 2件: ADRB1, ADRB2 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
39 cAMP signaling pathway 💬
 2件: ADRB1, ADRB2 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
40 cAMP signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
41 cAMP signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
42 Carbohydrate digestion and absorption 💬
 1件: CACNA1D 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
43 Carbohydrate digestion and absorption 💬
 1件: CACNA1D 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
44 Cardiac muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
45 Cardiac muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
46 Cellular senescence 💬
 1件: CACNA1D 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
47 Cellular senescence 💬
 1件: CACNA1D 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
48 cGMP-PKG signaling pathway 💬
 1件: ADRB1 💬 D00235 💬 Atenolol 1件: 167 💬
49 cGMP-PKG signaling pathway 💬
 1件: ADRB1 💬 D05127 💬 Nebivolol 4件: 17, 85, 113, 167 💬
50 cGMP-PKG signaling pathway 💬
 3件: ADRB1, ADRB2, ADRB3 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
51 cGMP-PKG signaling pathway 💬
 3件: ADRB1, ADRB2, ADRB3 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
52 cGMP-PKG signaling pathway 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
53 cGMP-PKG signaling pathway 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
54 cGMP-PKG signaling pathway 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
55 cGMP-PKG signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
56 cGMP-PKG signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
57 Chagas disease 💬
 1件: ACE 💬 D00624 💬 Perindopril 4件: 58, 113, 167, 222 💬
58 Chagas disease 💬
 1件: ACE 💬 D03753 💬 Perindopril 4件: 58, 113, 167, 222 💬
59 Chemical carcinogenesis - receptor activation 💬
 1件: ADRB1 💬 D00235 💬 Atenolol 1件: 167 💬
60 Chemical carcinogenesis - receptor activation 💬
 1件: ADRB1 💬 D05127 💬 Nebivolol 4件: 17, 85, 113, 167 💬
61 Chemical carcinogenesis - receptor activation 💬
 3件: ADRB1, ADRB2, ADRB3 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
62 Chemical carcinogenesis - receptor activation 💬
 3件: ADRB1, ADRB2, ADRB3 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
63 Chemical carcinogenesis - receptor activation 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
64 Chemical carcinogenesis - receptor activation 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
65 Cholinergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
66 Cholinergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
67 Circadian entrainment 💬
 2件: CACNA1C, CACNA1D 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
68 Circadian entrainment 💬
 2件: CACNA1C, CACNA1D 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
69 Coronavirus disease - COVID-19 💬
 1件: ACE 💬 D00624 💬 Perindopril 4件: 58, 113, 167, 222 💬
70 Coronavirus disease - COVID-19 💬
 1件: ACE 💬 D03753 💬 Perindopril 4件: 58, 113, 167, 222 💬
71 Coronavirus disease - COVID-19 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
72 Coronavirus disease - COVID-19 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
73 Coronavirus disease - COVID-19 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
74 Cortisol synthesis and secretion 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
75 Cortisol synthesis and secretion 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
76 Cortisol synthesis and secretion 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
77 Cortisol synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
78 Cortisol synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
79 Cushing syndrome 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
80 Cushing syndrome 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
81 Cushing syndrome 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
82 Cushing syndrome 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
83 Cushing syndrome 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
84 Diabetic cardiomyopathy 💬
 1件: ACE 💬 D00624 💬 Perindopril 4件: 58, 113, 167, 222 💬
85 Diabetic cardiomyopathy 💬
 1件: ACE 💬 D03753 💬 Perindopril 4件: 58, 113, 167, 222 💬
86 Diabetic cardiomyopathy 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
87 Diabetic cardiomyopathy 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
88 Diabetic cardiomyopathy 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
89 Diabetic cardiomyopathy 💬
 1件: REN 💬 D03208 💬 Aliskiren 3件: 66, 167, 222 💬
90 Dilated cardiomyopathy 💬
 1件: ADRB1 💬 D00235 💬 Atenolol 1件: 167 💬
91 Dilated cardiomyopathy 💬
 1件: ADRB1 💬 D05127 💬 Nebivolol 4件: 17, 85, 113, 167 💬
92 Dilated cardiomyopathy 💬
 1件: ADRB1 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
93 Dilated cardiomyopathy 💬
 1件: ADRB1 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
94 Dilated cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
95 Dilated cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
96 Dopaminergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
97 Dopaminergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
98 GABAergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
99 GABAergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
100 Gap junction 💬
 1件: ADRB1 💬 D00235 💬 Atenolol 1件: 167 💬
101 Gap junction 💬
 1件: ADRB1 💬 D05127 💬 Nebivolol 4件: 17, 85, 113, 167 💬
102 Gap junction 💬
 1件: ADRB1 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
103 Gap junction 💬
 1件: ADRB1 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
104 Glutamatergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
105 Glutamatergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
106 GnRH secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
107 GnRH secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
108 GnRH signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
109 GnRH signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
110 Growth hormone synthesis, secretion and action 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
111 Growth hormone synthesis, secretion and action 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
112 Hypertrophic cardiomyopathy 💬
 1件: ACE 💬 D00624 💬 Perindopril 4件: 58, 113, 167, 222 💬
113 Hypertrophic cardiomyopathy 💬
 1件: ACE 💬 D03753 💬 Perindopril 4件: 58, 113, 167, 222 💬
114 Hypertrophic cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
115 Hypertrophic cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
116 Insulin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
117 Insulin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
118 Long-term potentiation 💬
 1件: CACNA1C 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
119 Long-term potentiation 💬
 1件: CACNA1C 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
120 MAPK signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
121 MAPK signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
122 Neuroactive ligand-receptor interaction 💬
 1件: ADRB1 💬 D00235 💬 Atenolol 1件: 167 💬
123 Neuroactive ligand-receptor interaction 💬
 1件: ADRB1 💬 D05127 💬 Nebivolol 4件: 17, 85, 113, 167 💬
124 Neuroactive ligand-receptor interaction 💬
 3件: ADRB1, ADRB2, ADRB3 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
125 Neuroactive ligand-receptor interaction 💬
 3件: ADRB1, ADRB2, ADRB3 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
126 Neuroactive ligand-receptor interaction 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
127 Neuroactive ligand-receptor interaction 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
128 Neuroactive ligand-receptor interaction 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
129 Oxytocin signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
130 Oxytocin signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
131 Pathways in cancer 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
132 Pathways in cancer 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
133 Pathways in cancer 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
134 Pathways of neurodegeneration - multiple diseases 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
135 Pathways of neurodegeneration - multiple diseases 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
136 Phospholipase D signaling pathway 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
137 Phospholipase D signaling pathway 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
138 Phospholipase D signaling pathway 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
139 Prion disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
140 Prion disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
141 Regulation of lipolysis in adipocytes 💬
 1件: ADRB1 💬 D00235 💬 Atenolol 1件: 167 💬
142 Regulation of lipolysis in adipocytes 💬
 1件: ADRB1 💬 D05127 💬 Nebivolol 4件: 17, 85, 113, 167 💬
143 Regulation of lipolysis in adipocytes 💬
 3件: ADRB1, ADRB2, ADRB3 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
144 Regulation of lipolysis in adipocytes 💬
 3件: ADRB1, ADRB2, ADRB3 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
145 Renin secretion 💬
 1件: ACE 💬 D00624 💬 Perindopril 4件: 58, 113, 167, 222 💬
146 Renin secretion 💬
 1件: ACE 💬 D03753 💬 Perindopril 4件: 58, 113, 167, 222 💬
147 Renin secretion 💬
 1件: ADRB1 💬 D00235 💬 Atenolol 1件: 167 💬
148 Renin secretion 💬
 1件: ADRB1 💬 D05127 💬 Nebivolol 4件: 17, 85, 113, 167 💬
149 Renin secretion 💬
 3件: ADRB1, ADRB2, ADRB3 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
150 Renin secretion 💬
 3件: ADRB1, ADRB2, ADRB3 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
151 Renin secretion 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
152 Renin secretion 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
153 Renin secretion 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
154 Renin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
155 Renin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
156 Renin secretion 💬
 1件: REN 💬 D03208 💬 Aliskiren 3件: 66, 167, 222 💬
157 Renin-angiotensin system 💬
 1件: ACE 💬 D00624 💬 Perindopril 4件: 58, 113, 167, 222 💬
158 Renin-angiotensin system 💬
 1件: ACE 💬 D03753 💬 Perindopril 4件: 58, 113, 167, 222 💬
159 Renin-angiotensin system 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
160 Renin-angiotensin system 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
161 Renin-angiotensin system 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
162 Renin-angiotensin system 💬
 1件: REN 💬 D03208 💬 Aliskiren 3件: 66, 167, 222 💬
163 Retrograde endocannabinoid signaling 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
164 Retrograde endocannabinoid signaling 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
165 Salivary secretion 💬
 1件: ADRB1 💬 D00235 💬 Atenolol 1件: 167 💬
166 Salivary secretion 💬
 1件: ADRB1 💬 D05127 💬 Nebivolol 4件: 17, 85, 113, 167 💬
167 Salivary secretion 💬
 3件: ADRB1, ADRB2, ADRB3 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
168 Salivary secretion 💬
 3件: ADRB1, ADRB2, ADRB3 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
169 Serotonergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
170 Serotonergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
171 Taste transduction 💬
 1件: CACNA1C 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
172 Taste transduction 💬
 1件: CACNA1C 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
173 Thermogenesis 💬
 1件: ADRB3 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
174 Thermogenesis 💬
 1件: ADRB3 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
175 Tight junction 💬
 1件: CACNA1D 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
176 Tight junction 💬
 1件: CACNA1D 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
177 Type II diabetes mellitus 💬
 2件: CACNA1C, CACNA1D 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
178 Type II diabetes mellitus 💬
 2件: CACNA1C, CACNA1D 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬
179 Vascular smooth muscle contraction 💬
 1件: AGTR1 💬 D00523 💬 Irbesartan 4件: 66, 167, 168, 222 💬
180 Vascular smooth muscle contraction 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
181 Vascular smooth muscle contraction 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
182 Vascular smooth muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00619 💬 Verapamil 3件: 96, 140, 167 💬
183 Vascular smooth muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 3件: 96, 140, 167 💬

先頭へ